Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells. 2007

Yong Xia, and Zhi-Wu Dong, and Bao-Xiang Zhao, and Xiao Ge, and Ning Meng, and Dong-Soo Shin, and Jun-Ying Miao
Institute of Organic Chemistry, School of Chemistry and Chemical Engineering, Shandong University, Jinan 250100, China.

A series of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives were synthesized, and the effects of all the compounds on A549 cell growth were investigated. The results showed that all the nine compounds had inhibitory effects on the growth of A549 cells and induced the cell apoptosis. The study on structure-activity relationships and prediction of lipophilicities of compounds showed that compounds with logP values in the range of 3.12-4.94 had more inhibitory effects on the growth of A549 cells.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006834 Hydrazines Substituted derivatives of hydrazine (formula H2N-NH2). Hydrazide
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Yong Xia, and Zhi-Wu Dong, and Bao-Xiang Zhao, and Xiao Ge, and Ning Meng, and Dong-Soo Shin, and Jun-Ying Miao
November 2008, European journal of medicinal chemistry,
Yong Xia, and Zhi-Wu Dong, and Bao-Xiang Zhao, and Xiao Ge, and Ning Meng, and Dong-Soo Shin, and Jun-Ying Miao
July 2008, Bioorganic & medicinal chemistry letters,
Yong Xia, and Zhi-Wu Dong, and Bao-Xiang Zhao, and Xiao Ge, and Ning Meng, and Dong-Soo Shin, and Jun-Ying Miao
December 2011, European journal of medicinal chemistry,
Yong Xia, and Zhi-Wu Dong, and Bao-Xiang Zhao, and Xiao Ge, and Ning Meng, and Dong-Soo Shin, and Jun-Ying Miao
February 2017, Molecular and cellular biochemistry,
Yong Xia, and Zhi-Wu Dong, and Bao-Xiang Zhao, and Xiao Ge, and Ning Meng, and Dong-Soo Shin, and Jun-Ying Miao
July 2010, Bioorganic & medicinal chemistry,
Yong Xia, and Zhi-Wu Dong, and Bao-Xiang Zhao, and Xiao Ge, and Ning Meng, and Dong-Soo Shin, and Jun-Ying Miao
March 2009, Bioorganic & medicinal chemistry,
Yong Xia, and Zhi-Wu Dong, and Bao-Xiang Zhao, and Xiao Ge, and Ning Meng, and Dong-Soo Shin, and Jun-Ying Miao
October 2009, Bioorganic & medicinal chemistry,
Yong Xia, and Zhi-Wu Dong, and Bao-Xiang Zhao, and Xiao Ge, and Ning Meng, and Dong-Soo Shin, and Jun-Ying Miao
January 2013, PloS one,
Yong Xia, and Zhi-Wu Dong, and Bao-Xiang Zhao, and Xiao Ge, and Ning Meng, and Dong-Soo Shin, and Jun-Ying Miao
October 2003, Bioorganic & medicinal chemistry letters,
Yong Xia, and Zhi-Wu Dong, and Bao-Xiang Zhao, and Xiao Ge, and Ning Meng, and Dong-Soo Shin, and Jun-Ying Miao
August 2001, Farmaco (Societa chimica italiana : 1989),
Copied contents to your clipboard!